ORBIT - Opportunities in Receptor Biology for Industrial Translation
The ORBIT collaborative R&D initiative was launched by Sosei Heptares in January 2016 and keeps us at the cutting edge of GPCR scientific research.
We collaborate with leading academic groups and emerging biotechnology companies. The objective is to leverage the expertise of collaborators to seek out new links between GPCRs and diseases and to develop a better understanding of disease biology relating to a broad range of GPCR targets, thus creating transformative medicines.
We have established several collaborations with leading research groups at prestigious universities around the world under the ORBIT initiative:
Sosei Heptares welcomes applications for collaborations linking GPCRs to disease. Please contact us at firstname.lastname@example.org